Skip to content

Clinical trials

Hemophilia B trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia B Country / region: France Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20071
20081
20095
20102
20112
20125
20131
20145
20151
20171
20185
20194
20202
20215
20223
20234
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Recruiting7
Terminated5
Unknown status3
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S10
CSL Behring7
Pfizer6
Swedish Orphan Biovitrum4
ApcinteX Ltd3
Assistance Publique - Hôpitaux de Paris3
Wyeth is now a wholly owned subsidiary of Pfizer3
Bioverativ Therapeutics Inc.2
Genzyme, a Sanofi Company2
Baxalta now part of Shire1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia B54
Hemophilia A28
Blood Coagulation Disorders5
Hematologic Diseases5
Coagulation Protein Disorders4
Blood Coagulation Disorders, Inherited3
Genetic Diseases, Inborn3
Hemorrhagic Disorders3
Genetic Diseases, X-Linked2
Hemorrhage2

Trials

Showing 76 to 54 of 54. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.